Literature DB >> 34133924

The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity.

Chengxian Xu1, Shaogang Sun1, Travis Johnson2, Rong Qi3, Siyuan Zhang4, Jie Zhang5, Kai Yang6.   

Abstract

T regulatory (Treg) cells are crucial to maintain immune tolerance and repress antitumor immunity, but the mechanisms governing their cellular redox homeostasis remain elusive. We report that glutathione peroxidase 4 (Gpx4) prevents Treg cells from lipid peroxidation and ferroptosis in regulating immune homeostasis and antitumor immunity. Treg-specific deletion of Gpx4 impairs immune homeostasis without substantially affecting survival of Treg cells at steady state. Loss of Gpx4 results in excessive accumulation of lipid peroxides and ferroptosis of Treg cells upon T cell receptor (TCR)/CD28 co-stimulation. Neutralization of lipid peroxides and blockade of iron availability rescue ferroptosis of Gpx4-deficient Treg cells. Moreover, Gpx4-deficient Treg cells elevate generation of mitochondrial superoxide and production of interleukin-1β (IL-1β) that facilitates T helper 17 (TH17) responses. Furthermore, Treg-specific ablation of Gpx4 represses tumor growth and concomitantly potentiates antitumor immunity. Our studies establish a crucial role for Gpx4 in protecting activated Treg cells from lipid peroxidation and ferroptosis and offer a potential therapeutic strategy to improve cancer treatment.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B16 melanoma; Gpx4; T(H)17 responses; TCR stimulation; Treg cells; ferroptosis; lipid peroxidation; mitochondria; tumor immune evasion

Mesh:

Substances:

Year:  2021        PMID: 34133924     DOI: 10.1016/j.celrep.2021.109235

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  39 in total

1.  Inhibition of ALG3 stimulates cancer cell immunogenic ferroptosis to potentiate immunotherapy.

Authors:  Pei Liu; Cha Lin; Zheyu Liu; Chenchen Zhu; Zhongda Lin; Dan Xu; Jian Chen; Qian Huang; Chuan-Yuan Li; Linlin Hou; Ji-An Pan; Xinjian Liu
Journal:  Cell Mol Life Sci       Date:  2022-06-08       Impact factor: 9.261

2.  Abrogation of ARF6 in promoting erastin-induced ferroptosis and mitigating capecitabine resistance in gastric cancer cells.

Authors:  Donghua Geng; Huiying Wu
Journal:  J Gastrointest Oncol       Date:  2022-06

Review 3.  Metabolic communication in the tumour-immune microenvironment.

Authors:  Kung-Chi Kao; Stefania Vilbois; Chin-Hsien Tsai; Ping-Chih Ho
Journal:  Nat Cell Biol       Date:  2022-10-13       Impact factor: 28.213

Review 4.  Regulation of Treg Cell Metabolism and Function in Non-Lymphoid Tissues.

Authors:  Kai Yang
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

Review 5.  Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.

Authors:  Weitong Gao; Xueying Wang; Yang Zhou; Xueqian Wang; Yan Yu
Journal:  Signal Transduct Target Ther       Date:  2022-06-20

6.  Upregulation of Ferroptosis-Related Fanconi Anemia Group D2 is a Poor Prognostic Factor and an Indicator of Tumor Immune Cell Infiltration in Lung Adenocarcinoma.

Authors:  Jingtao Zhang; Dongli Wang; Xiubao Chen; Lingyun Ji; Minmin Yu; Minghao Guo; Dexin Zhang; Weida Chen; Fei Xu
Journal:  Front Genet       Date:  2022-05-11       Impact factor: 4.772

Review 7.  The Organelle-Specific Regulations and Epigenetic Regulators in Ferroptosis.

Authors:  Yixuan Zhang; Mingrui Li; Yiming Guo; Shuang Liu; Yongguang Tao
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

8.  Ferroptosis Markers Predict the Survival, Immune Infiltration, and Ibrutinib Resistance of Diffuse Large B cell Lymphoma.

Authors:  Xiang-Ping Yang; Liu Huang; Junmei Weng; Lian Chen; Huicheng Liu
Journal:  Inflammation       Date:  2022-01-22       Impact factor: 4.092

Review 9.  Targeting ferroptosis as a vulnerability in cancer.

Authors:  Guang Lei; Li Zhuang; Boyi Gan
Journal:  Nat Rev Cancer       Date:  2022-03-25       Impact factor: 69.800

Review 10.  Microenvironmental influences on T cell immunity in cancer and inflammation.

Authors:  Darren R Heintzman; Emilie L Fisher; Jeffrey C Rathmell
Journal:  Cell Mol Immunol       Date:  2022-01-17       Impact factor: 22.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.